ADAM10 and ADAM17 as Biomarkers Linked to Inflammation, Metabolic Disorders and Colorectal Cancer

ADAM10 and ADAM17 as Biomarkers Linked to Inflammation, Metabolic Disorders and Colorectal Cancer

ADAM10 and ADAM17 have a role in inflammation and diseases associated with inflammation, such as diabetes, cardiovascular diseases (CVD) or cancer, e.g., colorectal cancer (CRC). The aim of this study was to evaluate whether ADAM10 and ADAM17 could be biomarkers of CRC. To achieve this goal, CRC tum...

Full description

Bibliographic Details
Main Authors: Magdalena Sikora-Skrabaka, Katarzyna Weronika Walkiewicz, Ewa Nowakowska-Zajdel, Dariusz Waniczek, Joanna Katarzyna Strzelczyk
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Current Issues in Molecular Biology
Subjects:
ADAM10
ADAM17
colorectal cancer
biomarkers
diabetes mellitus type 2
cardiovascular diseases
Online Access:https://www.mdpi.com/1467-3045/44/10/309

Similar Items

Similar Items